Shares of Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as C$5.38 and last traded at C$5.31, with a volume of 55252 shares. The stock had previously closed at C$4.96.
Medexus Pharmaceuticals Stock Up 1.3%
The company has a market capitalization of C$170.01 million, a P/E ratio of -76.71 and a beta of 0.20. The company has a 50-day moving average of C$4.71 and a two-hundred day moving average of C$3.87.
About Medexus Pharmaceuticals
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Recommended Stories
- Five stocks we like better than Medexus Pharmaceuticals
- Cleared for Takeoff: Archer Aviation Changes the Math on eVTOL
- Voyager Technologies: Space Force Deal Fuels Growth Despite Heavy Cash Burn
- Franco-Nevada Earnings: Gold Is Rallying, But Does the Stock Even Care?
- GE Vernova’s AI Power Boom Faces a Profit Test
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg){kind=logo}
